NIVOLUMAB

nivolumab 40 mg/4 mL injection, 4 mL vial

NIVOLUMAB (11900H)

11900H
Body System:
Manner of administration:Injection
Public
Chemotherapy Items for Public Hospital use
Authority Required

Restriction

Indication: Stage IIIB, IIIC, IIID or Stage IV malignant melanoma
Treatment phase: Initial treatment

Restriction

Indication: Stage IIIB, IIIC, IIID or Stage IV malignant melanoma
Treatment phase: Continuing treatment
Quantities & Cost
Max amount # of repeats DPMA Max safety net General Patient Charge
Max amount: 480 mg # of repeats: 5 DPMA: $9,560.79 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Opdivo
(nivolumab 40 mg/4 mL injection, 4 mL vial)
Opdivo
(nivolumab 100 mg/10 mL injection, 10 mL vial)